Cytosorbents PE Ratio 2010-2025 | CTSO
Current and historical p/e ratio for Cytosorbents (CTSO) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cytosorbents PE ratio as of July 18, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Cytosorbents PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-18 | 1.03 | 0.00 | |
| 2025-03-31 | 1.00 | $-0.28 | 0.00 |
| 2024-12-31 | 0.91 | $-0.38 | 0.00 |
| 2024-09-30 | 1.50 | $-0.36 | 0.00 |
| 2024-06-30 | 0.70 | $-0.53 | 0.00 |
| 2024-03-31 | 0.95 | $-0.59 | 0.00 |
| 2023-12-31 | 1.11 | $-0.64 | 0.00 |
| 2023-09-30 | 1.88 | $-0.53 | 0.00 |
| 2023-06-30 | 3.59 | $-0.60 | 0.00 |
| 2023-03-31 | 3.37 | $-0.71 | 0.00 |
| 2022-12-31 | 1.55 | $-0.75 | 0.00 |
| 2022-09-30 | 1.36 | $-0.95 | 0.00 |
| 2022-06-30 | 2.19 | $-0.82 | 0.00 |
| 2022-03-31 | 3.19 | $-0.68 | 0.00 |
| 2021-12-31 | 4.19 | $-0.57 | 0.00 |
| 2021-09-30 | 8.12 | $-0.36 | 0.00 |
| 2021-06-30 | 7.55 | $-0.23 | 0.00 |
| 2021-03-31 | 8.68 | $-0.20 | 0.00 |
| 2020-12-31 | 7.97 | $-0.20 | 0.00 |
| 2020-09-30 | 7.98 | $-0.33 | 0.00 |
| 2020-06-30 | 9.90 | $-0.52 | 0.00 |
| 2020-03-31 | 7.73 | $-0.55 | 0.00 |
| 2019-12-31 | 3.85 | $-0.60 | 0.00 |
| 2019-09-30 | 5.03 | $-0.64 | 0.00 |
| 2019-06-30 | 6.61 | $-0.53 | 0.00 |
| 2019-03-31 | 7.57 | $-0.61 | 0.00 |
| 2018-12-31 | 8.08 | $-0.56 | 0.00 |
| 2018-09-30 | 12.90 | $-0.51 | 0.00 |
| 2018-06-30 | 11.40 | $-0.48 | 0.00 |
| 2018-03-31 | 7.05 | $-0.33 | 0.00 |
| 2017-12-31 | 6.50 | $-0.28 | 0.00 |
| 2017-09-30 | 6.20 | $-0.32 | 0.00 |
| 2017-06-30 | 4.30 | $-0.36 | 0.00 |
| 2017-03-31 | 4.50 | $-0.44 | 0.00 |
| 2016-12-31 | 5.45 | $-0.47 | 0.00 |
| 2016-09-30 | 6.40 | $-0.39 | 0.00 |
| 2016-06-30 | 4.55 | $-0.39 | 0.00 |
| 2016-03-31 | 3.92 | $-0.22 | 0.00 |
| 2015-12-31 | 5.57 | $-0.33 | 0.00 |
| 2015-09-30 | 6.31 | $-1.09 | 0.00 |
| 2015-06-30 | 6.14 | $-1.23 | 0.00 |
| 2015-03-31 | 13.19 | $-1.53 | 0.00 |
| 2014-12-31 | 9.95 | $-1.59 | 0.00 |
| 2014-09-30 | 5.75 | $-1.00 | 0.00 |
| 2014-06-30 | 6.05 | $-1.00 | 0.00 |
| 2014-03-31 | 5.75 | $-1.00 | 0.00 |
| 2013-12-31 | 3.13 | $-1.00 | 0.00 |
| 2013-09-30 | 2.50 | $-1.00 | 0.00 |
| 2013-06-30 | 3.00 | $-1.00 | 0.00 |
| 2013-03-31 | 2.94 | $-0.75 | 0.00 |
| 2012-12-31 | 3.25 | $-0.50 | 0.00 |
| 2012-09-30 | 3.29 | $-0.25 | 0.00 |
| 2012-06-30 | 3.20 | 0 | 0.00 |
| 2012-03-31 | 3.58 | 0 | 0.00 |
| 2011-12-31 | 4.00 | 0 | 0.00 |
| 2011-09-30 | 4.18 | 0 | 0.00 |
| 2011-06-30 | 5.08 | 0 | 0.00 |
| 2011-03-31 | 9.73 | 0 | 0.00 |
| 2010-12-31 | 3.50 | 0 | 0.00 |
| 2010-09-30 | 2.31 | 0 | 0.00 |
| 2010-06-30 | 2.18 | 0 | 0.00 |
| 2010-03-31 | 4.35 | 0 | 0.00 |
| 2009-12-31 | 4.75 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.064B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $215.166B | 25.24 |
| Boston Scientific (BSX) | United States | $153.330B | 38.39 |
| Stryker (SYK) | United States | $148.630B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.070B | 0.00 |
| Medtronic (MDT) | Ireland | $114.929B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.764B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.126B | 24.62 |
| ResMed (RMD) | United States | $37.818B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $34.781B | 16.51 |
| Agilent Technologies (A) | United States | $32.381B | 21.11 |
| Terumo (TRUMY) | Japan | $23.911B | 31.06 |
| Koninklijke Philips (PHG) | Netherlands | $23.688B | 16.62 |
| Insulet (PODD) | United States | $20.003B | 78.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.437B | 11.84 |
| Baxter (BAX) | United States | $14.251B | 10.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.214B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.705B | 23.33 |
| Lantheus Holdings (LNTH) | United States | $4.855B | 12.25 |
| Prestige Consumer Healthcare (PBH) | United States | $3.744B | 16.73 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Haemonetics (HAE) | United States | $3.485B | 15.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.307B | 27.48 |
| ICU Medical (ICUI) | United States | $3.014B | 22.23 |
| LeMaitre Vascular (LMAT) | United States | $1.802B | 40.29 |
| QuidelOrtho (QDEL) | United States | $1.721B | 11.84 |
| AtriCure (ATRC) | United States | $1.449B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.192B | 15.24 |
| Green Thumb Industries (GTBIF) | United States | $1.190B | 26.76 |
| Neogen (NEOG) | United States | $1.029B | 13.17 |
| BioLife Solutions (BLFS) | United States | $0.996B | 0.00 |
| InMode (INMD) | Israel | $0.878B | 8.85 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.619B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 4.97 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Surmodics (SRDX) | United States | $0.432B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.298B | 10.97 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.267B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.63 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.50 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.235B | 10.68 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.199B | 0.00 |
| Omeros (OMER) | United States | $0.197B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.73 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.52 |
| Nephros (NEPH) | United States | $0.039B | 52.07 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |